Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report

BACKGROUND: Hepatocellular carcinoma with neuroendocrine differentiation (HCC-NED) is a very rare subtype of primary liver cancer. Treatment allocation in these patients therefore remains a challenge. METHODS: We report the case of a 74-year-old man with a HCC-NED. The tumor was surgically removed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Marie-Anne, Nuciforo, Sandro, Coto-Llerena, Mairene, Gallon, John, Matter, Matthias S., Ercan, Caner, Vosbeck, Jürg, Terracciano, Luigi M., Soysal, Savas D., Boll, Daniel, Kollmar, Otto, Delaloye, Raphaël, Piscuoglio, Salvatore, Heim, Markus H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249908/
https://www.ncbi.nlm.nih.gov/pubmed/35789568
http://dx.doi.org/10.1038/s43856-022-00150-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249908/
https://www.ncbi.nlm.nih.gov/pubmed/35789568
http://dx.doi.org/10.1038/s43856-022-00150-3

Ejemplares similares